Printer Friendly

PacfiCare, WellPoint face questions on drug contracts. (Briefing).

PacifiCare Health Systems Inc. and WellPoint Health Networks Inc. said the U.S. attorney's office in Boston has subpoenaed documents relating to pharmaceutical marketing and contracts.

It's the second subpoena PacifiCare has received from the Boston U.S. attorney's office, the company said. In early 2000, PacifiCare received a subpoena related to a pharmaceutical product. PacifiCare has never been a target of the investigation, said Suzanne Shirley, a spokeswoman for the company.

WellPoint's pharmacy subsidiary, WellPoint Pharmacy Management, received a subpoena concerning its relationship with TAP Pharmaceuticals, said Ken Ferber, a spokesman for WellPoint. The subpoena requested information about Lupron, a TAP drug given to treat endometriosis, and Prevacid, used to treat ulcers.

Pharmacy benefits managers Caremark Rx Inc. and Express Scripts Inc. received similar subpoenas, according to press reports. Cigna Corp. said it was subpeonaed by a Philadelphia U.S. attorney's office.

Neither U.S. attorney's office would confirm or deny the investigations.
COPYRIGHT 2002 A.M. Best Company, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Comment:PacfiCare, WellPoint face questions on drug contracts. (Briefing).(Brief Article)
Publication:Best's Review
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 1, 2002
Words:154
Previous Article:Insurers to feel cinch of N.J. budget belt. (Briefing).
Next Article:Georgia Blues ordered to explain fees, calculation method to doctors. (Briefing).
Topics:


Related Articles
Letters.
Fine Tuning Your News Briefing.
Make sure your freelancer contract is air-tight.
WELLPOINT CRITICIZED FOR PAYOUTS.
Generic remedy: Pharmacists and physicians can become partners in lowering drug costs for insurers. (Health-Care Costs: Life/Health).
Supreme court weighs enforcement of arbitration clause in 'payday' loans.
Team briefing.
FDA may require more long-term data to approve psychiatric drugs.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters